• 12595 Citations
  • 56 h-Index

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Primo N Lara is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 32 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.



DeGregorio, M., Matthews, D., Felton, J. S., deVere White, R. W., Radke, K., Lloyd, K. K., Gandara, D. R., Beckett, L. A., Gregg, J., Luciw, P. A., Kung, H., Gumerlock, P. H., Mack, P., Evans, C. P., Lara, P. N., Lam, K., Chen, X., Kelly, K., Cherry, S. R., Shacklett, B., Chen, M., Lloyd, K. C., Marcu, L., Chew, H. K., Chaudhari, A. & Yu, A.

National Institutes of Health


Project: Research project

  • Research Output

    An open-label phase IB study to evaluate GSK3052230 in combination with paclitaxel and carboplatin, or docetaxel, in FGFR1-amplified non-small cell lung cancer

    Morgensztern, D., Karaseva, N., Felip, E., Delgado, I., Burdaeva, O., Dómine, M., Lara, P. N., Paik, P. K., Lassen, U., Orlov, S., Trigo, J., Shomova, M., Baker-Neblett, K., Vasquez, J., Wang, X., Yan, L., Mitrica, I., DeYoung, M. P. & Garrido, P., Oct 1 2019, In : Lung Cancer. 136, p. 74-79 6 p.

    Research output: Contribution to journalArticle

  • 1 Scopus citations

    A Population-Based Study of Incidence and Survival of 1588 Thymic Malignancies: Results From the California Cancer Registry

    Benjamin, D. J., Klapheke, A., Lara, P. N., Cress, R. D. & Riess, J., Jan 1 2019, (Accepted/In press) In : Clinical lung cancer.

    Research output: Contribution to journalArticle

  • Considerations for the Next Clinical Trial Evaluating the Role of Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma

    Kim, H. L., Mayerson, E., Lara, P. N., Messing, E., Tangen, C., Shuch, B. M. & Vaishampayan, U., Jan 1 2019, In : European Urology Focus.

    Research output: Contribution to journalComment/debate

  • 3 Scopus citations

    First-in-human study of mivebresib (ABBV-075), an oral pan-inhibitor of bromodomain and extra terminal proteins, in patients with relapsed/ refractory solid tumors

    Piha-Paul, S. A., Sachdev, J. C., Barve, M., LoRusso, P., Szmulewitz, R., Patel, S. P., Lara, P. N., Chen, X., Hu, B., Freise, K. J., Modi, D., Sood, A., Hutti, J. E., Wolff, J. & O'Neil, B. H., Nov 1 2019, In : Clinical Cancer Research. 25, 21, p. 6309-6319 11 p.

    Research output: Contribution to journalArticle

    Open Access
  • 1 Scopus citations

    Genomic Drivers of Poor Prognosis and Enzalutamide Resistance in Metastatic Castration-resistant Prostate Cancer

    Chen, W. S., Aggarwal, R., Zhang, L., Zhao, S. G., Thomas, G. V., Beer, T. M., Quigley, D. A., Foye, A., Playdle, D., Huang, J., Lloyd, P., Lu, E., Sun, D., Guan, X., Rettig, M., Gleave, M., Evans, C. P., Youngren, J., True, L., Lara, P. N. & 8 others, Kothari, V., Xia, Z., Chi, K. N., Reiter, R. E., Maher, C. A., Feng, F. Y., Small, E. J. & Alumkal, J. J., Jan 1 2019, In : European Urology.

    Research output: Contribution to journalArticle

  • 8 Scopus citations